Home

CYTRX CORP

CIK 799698 · last filed 2010-12-30

CYTRX CORP is a corporate insider who has filed 6 SEC Form 4 insider transactions across 1 company since 2008. The most recent filing shows the insider sold $5.7M of RXII on Dec 30, 2010. Across all open-market trades the lifetime net is −$17.2M, making them a net seller over the disclosed history. The firm reports its address in Los Angeles, CA. 24 SEC filings were submitted jointly with STEVEN A KRIEGSMAN.

"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.

Loading insider history…
Disclosed Exposure

$0

Companies

1

Total Filings

6

Lifetime Open-Market Net

-$17.23M

Filer Profile

Reported Address
11726 SAN VICENTE BOULEVARD
SUITE 650
LOS ANGELES, CA 90049
Phone
(310) 826-5648
State of Incorporation
DE
Formerly Known As
CYTRX CORP (1995–2022)
Related Filers
STEVEN A KRIEGSMAN — 24 joint filings, latest 2020-08-13
LOUIS IGNARRO — 21 joint filings, latest 2020-08-13
Scott Bradford Patterson — 21 joint filings, latest 2016-12-27
JOHN Y CALOZ — 19 joint filings, latest 2024-01-29
JOSEPH RUBINFELD — 17 joint filings, latest 2016-12-19
Ben Levin — 16 joint filings, latest 2015-12-17
Richard L. Wennekamp — 16 joint filings, latest 2014-12-16
MAX LINK — 15 joint filings, latest 2013-12-12
Profile details as reported on the filer's SEC submissions — for individual insiders the address is often in care of the issuer. Related filers are identified from jointly filed SEC submissions and shared reported addresses. View filings on SEC EDGAR.

Holdings By Company

Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
Symbol Role Shares Price Disclosed Exposure Lifetime OM Net Filings Latest Filed
SELLAS Life Sciences Group, Inc. (RXII) Delisted 10%+ Owner 0 — — -$17.23M 6 2010-12-30

Recent Filings

6 filings
Insider activity across all companies, newest first. Form 4 rows are post-trade confirmations (buys, sells, grants, exercises). Notice (144) rows are pre-trade notices of intent to sell restricted or control stock under Rule 144 — they may not all execute. Compare adjacent dates to see which notices became actual sales.
Filed Symbol Action Net Shares Net $ Link
2010-12-30 SELLAS Life Sciences Group, Inc. (RXII) Delisted Sell (S) −2,593,881 -$5.71M EDGAR
2010-12-23 SELLAS Life Sciences Group, Inc. (RXII) Delisted Sell (S) −500,000 -$1.32M EDGAR
2010-07-02 SELLAS Life Sciences Group, Inc. (RXII) Delisted Sell (S) −675,000 -$3.85M EDGAR
2010-07-02 SELLAS Life Sciences Group, Inc. (RXII) Delisted Sell (S) −2,000,000 -$5.10M EDGAR
2009-09-25 SELLAS Life Sciences Group, Inc. (RXII) Delisted Sell (S) −500,000 -$1.25M EDGAR
2008-03-12 SELLAS Life Sciences Group, Inc. (RXII) Delisted Other (J) −4,554,318 $0 EDGAR
Form 4 codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.